Goshonoside F5
CAS: 90851-28-8
Ref. 3D-QDA85128
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Product Information
- β-D-Glucopyranoside, (2E)-5-[(1R,4aS,5S,6R,8aS)-5-[(β-D-glucopyranosyloxy)methyl]decahydro-6-hydroxy-5,8a-dimethyl-2-methylene-1-naphthalenyl]-3-methyl-2-pentenyl
- Goshonoside F 5
- (2E)-5-[(1R,4aS,5S,6R,8aS)-5-[(β-D-Glucopyranosyloxy)methyl]decahydro-6-hydroxy-5,8a-dimethyl-2-methylene-1-naphthalenyl]-3-methyl-2-penten-1-yl β-D-glucopyranoside
- β-D-Glucopyranoside, (2E)-5-[(1R,4aS,5S,6R,8aS)-5-[(β-D-glucopyranosyloxy)methyl]decahydro-6-hydroxy-5,8a-dimethyl-2-methylene-1-naphthalenyl]-3-methyl-2-penten-1-yl
- β-D-Glucopyranoside, 5-[5-[(β-D-glucopyranosyloxy)methyl]decahydro-6-hydroxy-5,8a-dimethyl-2-methylene-1-naphthalenyl]-3-methyl-2-pentenyl, [1R-[1α(E),4aβ,5β,6α,8aα]]-
Goshonoside F5 is a clinical medication that has been shown to inhibit the production of inflammatory cytokines such as IL-1 and TNF-α. Goshonoside F5 inhibits the activation of NF-κB and COX-2, which are two inflammatory mediators. This active form is an alcohol extract from schisandra fruit, fructus, or cox-2 gene reconstituted in water. The excipients are homogenized and insoluble in water. Goshonoside F5 can be used for the treatment of acute kidney injury and other health care products. It also has been shown to inhibit markers related to inflammation, such as IL-6 and CXCL1.
Chemical properties
Technical inquiry about: 3D-QDA85128 Goshonoside F5
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.